S H Kelkar & CompanyQ3 FY24

S H Kelkar & Company Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹128.64P/E: 33.2Market Cap: ₹1.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

No

Capex

No

0 of 5 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Company targets a 10-12% year-on-year revenue growth for the mid-term (3 to 5 years), with potential to exceed this based on current strong order wins.
  • Growth is expected across all regions including Europe, India, Southeast Asia, and new markets like the US.
  • Volume growth outpaces price increases; last quarter’s growth primarily driven by volume with minimal price impact (~1-2%).
  • Market share expansion in India and growth in Flavours segment anticipated to contribute materially.
  • New product introductions and new accounts (including wins from a global MNC) expected to add meaningful revenue from H2 FY25 onwards.
  • Southeast Asia factory commissioning to boost regional growth.
  • Lower capacity utilization (<50%) allows for operating leverage and volume growth without major capex in near term.
  • E-commerce and startup segments in India identified as growth drivers.
  • Overall, sustained double-digit growth in volume and sales targeted with a focus on market penetration and operational efficiency.

See what S H Kelkar & Company management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
- The company does not expect any large capex or inorganic growth in the near future, having completed significant acquisitions in the past 4 years. - Current debt stands around Rs. 500 crore, primarily from acquisitions. - Cash flows are expected to bring down the debt. - There is no mention of plans for new debt or equity fundraising. - Capital allocation policy includes distributing 30-40% of cash profit as dividends or share buyback. - The last major outlay was for the Indonesia project; no major future capex is lined up. - Incremental capex on product development and infrastructure is planned but not large-scale fundraising. **Conclusion:** No new major fundraising through debt or equity is planned currently or in the near future.

See what S H Kelkar & Company management said on order book — free account, 30 seconds.

Capex plans

No
  • Current large capex: Indonesia factory, expected to be ready by next financial year.
  • No large production capex expected in the coming year; focus on incremental capex.
  • Incremental capex targeted at product development teams and infrastructure to support growth and diverse projects.
  • Product development teams expected to double or triple in the next 3-4 years.
  • European facilities (Italy and Netherlands) optimized for increased production without significant capex currently.
  • Possible new manufacturing or development capex in Europe anticipated around 18 months from now (2025-26).
  • No major inorganic acquisitions planned; focus on organic growth through subsidiaries in the US and Europe.
  • Capital allocation policy involves distributing 30-40% of cash profit as dividends or share buybacks; incremental cash likely to be used for debt repayment.

Track S H Kelkar & Company — get its next earnings analysis in your feed

How does S H Kelkar & Company rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisS H Kelkar & Company
Rev 3Mar 3

How does S H Kelkar & Company rank in Chemicals & Petrochemicals?

Compare S H Kelkar & Company against every Chemicals & Petrochemicals company (Q3 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →